Zortix
Ask Zortix…⌘KSign in

What finance podcasts are saying aboutModerna Inc.MRNANASDAQ

According to Zortix's podcast index, Moderna Inc. (MRNA) was discussed on 2 finance podcasts across 3 episodes in the 30 days to 19 Oct 2026, generating 5 attributed ideas, most coverage from CNBC Fast Money and The Derivative.

Mentions · 7d
2
Mentions · 30d
5
Mentions · 90d
31
Shows · 30d
2
Episodes · 30d
3
Vs prior week
0
Discussion depth
Substantive discussion
As of 15 Oct 2026
Ask Zortix about MRNA

Latest ideas · headlines, attributed

15 OCT4D AGOTHE DERIVATIVE · ADRIAN KEEVIL
15 OCT4D AGOTHE DERIVATIVE · ADRIAN KEEVIL
SHOWS SPLIT3 SHOWS · NOT ALL ON THE SAME SIDEOpen in Zortix →Thesis and listen link in the app
9 OCT1W AGOCNBC FAST MONEY
SHOWS SPLIT3 SHOWS · NOT ALL ON THE SAME SIDEOpen in Zortix →Thesis and listen link in the app

Discussed alongside MRNA · 90 days

  1. MRKMerck & Co. Inc.in 5 ideas
  2. LLYEli Lilly and Companyin 1 idea
  3. XBISPDR S&P Biotech ETFin 1 idea

Definitions

Mention
One attributed idea naming this ticker, extracted from a podcast episode and dated by the episode’s air date. How we count →
Attributed idea
A specific argument a named speaker made on a named show, never an aggregate opinion, never Zortix’s view. What qualifies →
Discussion depth
How thoroughly an idea was argued on the episode, from a brief mention to a core thesis (a description of the conversation, not a rating of the stock). The bands →
Stance mix
Counts of attributed ideas by the side each argued on this name (bullish, balanced, or bearish as the speaker put it). A tally of the conversation’s sides, never a combined score, a rating, or Zortix’s view.
MENTIONS, DEPTH, STANCE MIX & COVERAGE REFLECT PODCAST DISCUSSION · NOT A RATING, FORECAST, OR RECOMMENDATION